Rankings
▼
Calendar
BVS (Bioventus Inc.) Stock Financials & Earnings | Market Cap Arena
BVS
Bioventus Inc.
Mkt Cap
$593M
Healthcare
·
Medical - Devices
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$568M
Net Income (TTM)
$23M
EPS (TTM)
$0.33
Free Cash Flow (TTM)
$72M
Gross Margin
68.1%
Op. Margin
10.3%
Net Margin
4.0%
FCF Margin
12.7%
P/S Ratio (TTM)
1.0x
P/E Ratio (TTM)
26.1x
YoY Rev Growth
-0.9%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$119M
$74M
-$92M
Q2 23
$137M
$89M
$7M
Q3 23
$121M
$79M
$2M
Q4 23
$135M
$86M
$1M
Q1 24
$129M
$88M
$5M
Q2 24
$151M
$104M
-$31M
Q3 24
$139M
$94M
$4M
Q4 24
$154M
$103M
$8M
Q1 25
$124M
$83M
$5M
Q2 25
$148M
$102M
$18M
Q3 25
$139M
$93M
$12M
Q4 25
$158M
$109M
$23M
marketcaparena.com
Revenue Breakdown
BVS
Bioventus Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
1.2x
—
Q2 23
1.2x
—
Q3 23
1.2x
—
Q4 23
1.2x
—
Q1 24
1.1x
—
Q2 24
1.1x
—
Q3 24
1.1x
—
Q4 24
1.0x
—
Q1 25
1.0x
—
Q2 25
1.1x
—
Q3 25
1.1x
75.8x
Q4 25
1.0x
26.1x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$2M
-$1M
Q2 23
$11M
$9M
Q3 23
-$8M
-$10M
Q4 23
$10M
$10M
Q1 24
-$6M
-$6M
Q2 24
$15M
$15M
Q3 24
$10M
$10M
Q4 24
$19M
$19M
Q1 25
-$19M
-$20M
Q2 25
$26M
$25M
Q3 25
$30M
$30M
Q4 25
$38M
$37M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$4M
Q2 23
$1M
Q3 23
$2M
Q4 23
$369K
Q1 24
$291K
Q2 24
$77K
Q3 24
$64K
Q4 24
$574K
Q1 25
$826K
Q2 25
$683K
Q3 25
$473K
Q4 25
$580K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+1.5%
+52.2%
Q2 23
-2.3%
-9.3%
Q3 23
-6.1%
-53.7%
Q4 23
+7.6%
-11.2%
Q1 24
+8.7%
-41.0%
Q2 24
+10.3%
+40.2%
Q3 24
+15.0%
+14.0%
Q4 24
+13.5%
+8.5%
Q1 25
-4.3%
-4.4%
Q2 25
-2.4%
-29.2%
Q3 25
-0.2%
-6.2%
Q4 25
+2.8%
-7.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$2M
1.6%
Q2 23
-$3M
-2.0%
Q3 23
$2M
1.5%
Q4 23
$0
0.0%
Q1 24
$3M
2.0%
Q2 24
$4M
2.4%
Q3 24
$2M
1.5%
Q4 24
$2M
1.1%
Q1 25
$2M
1.9%
Q2 25
$4M
2.5%
Q3 25
$0
0.0%
Q4 25
$3M
2.2%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$4M
$81M
Q2 23
$3M
$75M
Q3 23
$3M
$70M
Q4 23
$3M
$78M
Q1 24
$3M
$79M
Q2 24
$4M
$97M
Q3 24
$4M
$81M
Q4 24
$3M
$87M
Q1 25
$3M
$74M
Q2 25
$3M
$79M
Q3 25
$3M
$78M
Q4 25
$3M
$83M
marketcaparena.com
Revenue Segments
International Segment
U.S. Segment
Quarter
International Segment
U.S. Segment
Q1 24
$15M
$114M
Q2 24
$17M
$134M
Q3 24
$16M
$123M
Q4 24
$18M
$135M
Q1 25
$13M
$111M
Q2 25
$19M
$129M
Q3 25
$15M
$123M
Q4 25
$18M
$139M
marketcaparena.com
Revenue by Geography
Non-US
United States
Quarter
Non-US
United States
Q3 23
$15M
$106M
Q1 24
$15M
$114M
Q2 24
$17M
$134M
Q3 24
$16M
$123M
Q4 24
$18M
$135M
Q1 25
$13M
$111M
Q2 25
$19M
$129M
Q3 25
$15M
$123M
Q4 25
$18M
$139M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$47M
$0
$47M
Q2 23
$29M
$0
$29M
Q3 23
$27M
$0
$27M
Q4 23
$37M
$0
$37M
Q1 24
$25M
$0
$25M
Q2 24
$32M
$0
$32M
Q3 24
$43M
$0
$43M
Q4 24
$42M
$0
$42M
Q1 25
$23M
$0
$23M
Q2 25
$33M
$0
$33M
Q3 25
$42M
$0
$42M
Q4 25
$51M
$0
$51M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
62M
+0.3%
Q2 23
63M
+0.7%
Q3 23
63M
+0.4%
Q4 23
63M
+0.3%
Q1 24
63M
+0.6%
Q2 24
64M
+1.1%
Q3 24
65M
+1.9%
Q4 24
65M
+0.3%
Q1 25
66M
+0.9%
Q2 25
69M
+3.8%
Q3 25
69M
+0.4%
Q4 25
69M
+0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
—
—
FY 16
—
—
FY 17
—
—
FY 18
—
—
FY 19
—
—
FY 20
$459K
700
FY 21
$359K
1K
FY 22
$457K
1K
FY 23
$528K
970
FY 24
$616K
930
FY 25
$611K
930
marketcaparena.com